AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 163 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $250,200 | -30.2% | 180,000 | 0.0% | 0.04% | -32.8% |
| Q4 2022 | $358,200 | -1.6% | 180,000 | 0.0% | 0.06% | -7.9% |
| Q3 2022 | $364,000 | -36.4% | 180,000 | 0.0% | 0.06% | -36.4% |
| Q2 2022 | $572,000 | -23.8% | 180,000 | 0.0% | 0.10% | -32.2% |
| Q1 2022 | $751,000 | -12.9% | 180,000 | 0.0% | 0.15% | -22.8% |
| Q4 2021 | $862,000 | -10.3% | 180,000 | 0.0% | 0.19% | -10.8% |
| Q3 2021 | $961,000 | +4.2% | 180,000 | 0.0% | 0.21% | +11.0% |
| Q2 2021 | $922,000 | -23.9% | 180,000 | 0.0% | 0.19% | -23.3% |
| Q1 2021 | $1,211,000 | +115.5% | 180,000 | +46.3% | 0.25% | +69.4% |
| Q4 2020 | $562,000 | +41.9% | 123,000 | +20.6% | 0.15% | +40.0% |
| Q3 2020 | $396,000 | -85.7% | 102,000 | -18.4% | 0.10% | -86.9% |
| Q3 2018 | $2,774,000 | -15.5% | 125,000 | -37.5% | 0.80% | -8.9% |
| Q2 2018 | $3,282,000 | – | 200,000 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |